Elias Matouk
QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Triple potentiator combinations increase the functional correction of several CFTR gating mutants.
Journal: npj drug discovery
Published: November 21, 2025
Genomic Epidemiology of Mycobacterium abscessus on the Island of Montréal Is Not Suggestive of Health Care-Associated Person-to-Person Transmission.
Journal: The Journal of infectious diseases
Published: January 29, 2024
Efficacy and safety of LAU-7b in a Phase 2 trial in adults with cystic fibrosis.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: January 08, 2024
Development and Evaluation of a Height-Based Tobramycin Initial Dosing Nomogram for the Treatment of Adult Cystic Fibrosis Pulmonary Exacerbations.
Journal: Therapeutic drug monitoring
Published: June 08, 2022
New Recommendations of a Height-Based Dosing Regimen of Tobramycin for Cystic Fibrosis in Adults: A Population Pharmacokinetic Analysis.
Journal: Therapeutic drug monitoring
Published: April 12, 2022
A Precision Medicine Approach to Optimize Modulator Therapy for Rare CFTR Folding Mutants.
Journal: Journal of personalized medicine
Published: June 16, 2021
Large pH oscillations promote host defense against human airways infection.
Journal: The Journal of experimental medicine
Published: August 26, 2020
Amikacin nomogram for treatment of adult cystic fibrosis exacerbations based on an external evaluation of a population pharmacokinetic model.
Journal: Pediatric pulmonology
Published: September 30, 2019
Mutation-specific dual potentiators maximize rescue of CFTR gating mutants.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: August 27, 2019
Structure-guided combination therapy to potently improve the function of mutant CFTRs.
Journal: Nature medicine
Published: August 28, 2017
Last Updated: 09/26/2026